Simple Summary Medulloblastoma is the commonest malignant brain tumour of childhood.
Disease relapse following maximal multi-modal therapy including upfront craniospinal …

Purpose: To analyze the risk and benefit of high-dose chemotherapy followed by stem cell
transplantation (HDCT-SCT) treatment in patients with advanced retinoblastoma. Design …

Purpose Molecular subgrouping of medulloblastoma has become important due to its impact
on risk group stratification. Immunohistochemistry (IHC) has been widely used but it has …

Early studies with high-dose chemotherapy for treatment of relapsed cerebral PNET had
shown modest efficacy but considerable toxicity. The HIT97 national trial tested a …

Purpose To assess the results and tolerance of radiosurgery/hypofractionated stereotactic
radiotherapy performed after craniospinal irradiation for recurrent tumor. Methods Fourteen …

101例儿童复发髓母细胞瘤的序贯治疗生存分析- PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

Purpose The treatment outcome of pediatric refractory or relapsed brain tumor is very
dismal, and effective salvage chemotherapy is not established. The combination of …

The prognosis of brain tumors in children has improved for last a few decades. However, the
prognosis remains dismal in patients with recurrent brain tumors. The outcome for infants …

Purpose We aimed to determine the current application and survival trends of hematopoietic
stem cell transplantation (HSCT) among Korean children and adolescents with cancer …

Medulloblastoma accounts for almost one-third of pediatric central nervous system (CNS)
cancers, but is very rare in the adult population. As a result, adult patients with …